DK1129720T3 - Stabiliseret granulocyt-kolonistimulerende faktor - Google Patents

Stabiliseret granulocyt-kolonistimulerende faktor

Info

Publication number
DK1129720T3
DK1129720T3 DK01301576T DK01301576T DK1129720T3 DK 1129720 T3 DK1129720 T3 DK 1129720T3 DK 01301576 T DK01301576 T DK 01301576T DK 01301576 T DK01301576 T DK 01301576T DK 1129720 T3 DK1129720 T3 DK 1129720T3
Authority
DK
Denmark
Prior art keywords
stimulating factor
colony stimulating
granulocyte colony
stabilized
salt
Prior art date
Application number
DK01301576T
Other languages
Danish (da)
English (en)
Inventor
Josephine Nanette Hay
Kathleen Brimelow Williams
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1129720T3 publication Critical patent/DK1129720T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK01301576T 2000-02-29 2001-02-21 Stabiliseret granulocyt-kolonistimulerende faktor DK1129720T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18576900P 2000-02-29 2000-02-29

Publications (1)

Publication Number Publication Date
DK1129720T3 true DK1129720T3 (da) 2004-09-27

Family

ID=22682387

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01301576T DK1129720T3 (da) 2000-02-29 2001-02-21 Stabiliseret granulocyt-kolonistimulerende faktor

Country Status (11)

Country Link
US (1) US6497869B2 (de)
EP (1) EP1129720B1 (de)
JP (1) JP3544180B2 (de)
AT (1) ATE269716T1 (de)
BR (1) BR0100827A (de)
CA (1) CA2337661A1 (de)
DE (1) DE60103940T2 (de)
DK (1) DK1129720T3 (de)
ES (1) ES2220673T3 (de)
PT (1) PT1129720E (de)
TR (1) TR200401573T4 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
EP1450847B1 (de) * 2001-11-13 2010-09-29 Genentech, Inc. Zusammensetzungen basierend auf APO2-Ligand/ TRAIL und ihre Verwendung
US7220407B2 (en) 2003-10-27 2007-05-22 Amgen Inc. G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
CN1878570B (zh) * 2003-11-04 2010-10-06 力奇制药公司 包含粒细胞集落形成刺激因子的稳定的药物组合物
MX2007015039A (es) * 2005-06-06 2008-01-24 Novo Nordisk As Composiciones de il-21 estabilizadas.
KR100812274B1 (ko) * 2006-10-30 2008-03-13 한양대학교 산학협력단 Ｇ-ｃｓｆ를 유효성분으로 하는 당뇨성 말초신경병 예방 및치료제
DE102007040932A1 (de) 2007-08-27 2009-03-05 Biogenerix Ag Flüssigformulierung von G-CSF
MX2010002348A (es) 2007-08-27 2010-07-30 Biogenerix Ag Formulacion liquida de g-csf.
CN102159230A (zh) 2008-07-23 2011-08-17 Ambrx公司 经修饰的牛g-csf多肽和其用途
JP5769379B2 (ja) * 2010-03-17 2015-08-26 グンゼ株式会社 Ｄａｎｃｅタンパク質溶液
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
ITMI20120338A1 (it) * 2012-03-06 2013-09-07 Dr Andrea Bignotti Preparato terapeutico e procedimento di preparazione di detto preparato terapeutico
WO2017067959A1 (en) * 2015-10-19 2017-04-27 Sandoz Ag Method for producing a recombinant protein with reduced impurities

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810643A (en) 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
GR871067B (en) * 1986-07-18 1987-11-19 Chugai Pharmaceutical Co Ltd Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor
GB2193621A (en) 1986-07-29 1988-02-17 Jan Mazura Plant support line
KR0133561B1 (ko) 1988-05-13 1998-04-21 스티븐 엠. 오드레 과립구 군체 자극인자의 정제방법
US5104651A (en) 1988-12-16 1992-04-14 Amgen Inc. Stabilized hydrophobic protein formulations of g-csf
AU641949B2 (en) 1989-10-10 1993-10-07 Amgen, Inc. Compositions and methods for treating or preventing infections in canine and feline animals
GB9107846D0 (en) 1990-04-30 1991-05-29 Ici Plc Polypeptides
IE912365A1 (en) 1990-07-23 1992-01-29 Zeneca Ltd Continuous release pharmaceutical compositions
DE4126983A1 (de) 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
FR2686900B1 (fr) 1992-01-31 1995-07-21 Rhone Poulenc Rorer Sa Nouveaux polypeptides ayant une activite de stimulation des colonies de granulocytes, leur preparation et compositions pharmaceutiques les contenant.
FR2693907B1 (fr) 1992-07-23 1994-09-02 Rhone Poulenc Rorer Sa Procédé d'administration de solutions de facteur de stimulation des colonies granulocytaires.
DE4242919A1 (de) * 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Verfahren zur Herstellung von lagerstabilen wässrigen pharmazeutischen Zubereitungen von G-CSF
DE4242863A1 (de) 1992-12-18 1994-06-23 Boehringer Mannheim Gmbh Stabile lyophilisierte pharmazeutische Zubereitungen von G-CSF
NZ271181A (en) 1993-07-19 1998-06-26 Amgen Inc Protein protection; method for stabilising aerosolised proteins by adding a water-soluble polar organic compound to the aqueous solution prior to aerosolisation
US5874075A (en) 1993-10-06 1999-02-23 Amgen Inc. Stable protein: phospholipid compositions and methods
US5824784A (en) 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
ATE260674T1 (de) * 1998-08-17 2004-03-15 Pfizer Prod Inc Stabilisierte proteinzusammensetzung

Also Published As

Publication number Publication date
TR200401573T4 (tr) 2004-08-23
ES2220673T3 (es) 2004-12-16
EP1129720A3 (de) 2001-09-26
DE60103940D1 (de) 2004-07-29
ATE269716T1 (de) 2004-07-15
EP1129720A2 (de) 2001-09-05
CA2337661A1 (en) 2001-08-29
DE60103940T2 (de) 2005-07-28
EP1129720B1 (de) 2004-06-23
PT1129720E (pt) 2004-08-31
BR0100827A (pt) 2001-11-27
JP2001278898A (ja) 2001-10-10
JP3544180B2 (ja) 2004-07-21
US6497869B2 (en) 2002-12-24
US20020002133A1 (en) 2002-01-03

Similar Documents

Publication Publication Date Title
DE60103940D1 (de) Stabilisierter Granulozyten-Kolonie-stimulierender Faktor
BR0104326B1 (pt) ôcomposição aquosa de revestimentoö.
DE60219383D1 (de) Wässrige Beschichtungszusammensetzung
CA2336845A1 (en) Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
AU8911901A (en) Aqueous nanocomposite dispersions: processes, compositions, and uses thereof
MX355976B (es) Composiciones antitranspirantes de eficacia mejorada que contienen estroncio.
BRPI0317696B8 (pt) composição para branqueamento
ZA200205749B (en) Stabilized aqueous acidic antiperspirant compositions and related methods.
DE60113822D1 (de) Haarwachstumsfördernde zusammensetzungen
EP1236398A4 (de) Mikrobizide zusammensetzungen
TWI317736B (en) Methods for the production of redox proteins and heteromultimeric-protein-complexes, and related compositions related applications
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
WO2002017921A3 (en) Paroxetine compositions and processes for making the same
DE60138100D1 (de) Wässrige beschichtungszusammensetzung
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
MY147790A (en) Stable emulsion composition
ATE536886T1 (de) Stabilisierte feste zusammensetzungen von modifizierter faktor vii
ATE450652T1 (de) Wässrige zusammensetzung
GB2387101A (en) Compositions containing creatine and creatinine
BR0113783B1 (pt) Composição aquosa
CA2406492A1 (en) All natural mineral treatment
ATE294154T1 (de) Apfelsäureadditionssalze von terbinafin
DE60124516D1 (de) Kombination des lezithins mit ascorbinsäure
DE60124839D1 (de) Wässrige Beschichtungszusammensetzung
WO2003051297A3 (en) Aqueous ifosfamide composition